Purchases and Sales Made in Q3 2022 in Tarsus Pharmaceuticals, Inc. (TARS)
This table provides information about the institutional ownership of Tarsus Pharmaceuticals, Inc. (TARS) during Q3 2022. The information is specifically focused on institutions that hold shares of Tarsus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-6.87K- 26.7% |
$96.7K - $127K
|
18.9K
$925K
|
|
|
Nov 14, 2022
Q3 2022
|
J. Goldman & CO LP
New York, NY |
SELL
|
- |
-9.25K- 18.21% |
$130K - $171K
|
41.6K
$2.04M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-10.8K- 30.89% |
$153K - $201K
|
24.3K
$1.19M
|
|
|
Nov 07, 2022
Q3 2022
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-11.7K- 48.75% |
$165K - $216K
|
12.3K
$604K
|
|
|
Nov 14, 2022
Q3 2022
|
Cowen And Company, LLC
|
SELL
|
- |
-12.2K- 2.28% |
$172K - $226K
|
522K
$25.6M
|
|
|
Nov 14, 2022
Q3 2022
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-13.2K- 70.66% |
$186K - $244K
|
5.48K
$269K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-13.3K- 53.42% |
$188K - $247K
|
11.6K
$570K
|
|
|
Nov 14, 2022
Q3 2022
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-50.2K- 2.17% |
$706K - $928K
|
2.26M
$111M
|
|
|
Oct 27, 2022
Q3 2022
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-159K- 44.04% |
$2.24M - $2.95M
|
202K
$9.94M
|